About Technology Issues FAQ

Links

Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment

Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.